Search Results

Clearwater France advises MBO Partenaires on the acquisition of BCF Life Sciences

Sébastien Allegot

I joined Clearwater in 2017 and have worked across the industrials & chemicals, healthcare and real estate sectors. A personal highlight of mine was working on the acquisition by MBO Partenaires of BCF Life Sciences from Céréa Partenaires and Sodero Gestion in 2018. During this transaction our team was able to help our client reach a successful outcome in a competitive process. I was attracted to joining Clearwater because of its reputation in mid-market transactions and its multi-sector expertise, while joining a growing business was another strong reason for my choice. Prior to joining Clearwater I worked in M&A at Degroof Petercam in Paris after graduating with a MSc in Corporate Finance from ESCP, and from ECE Paris with a major in Financial Engineering.

Clearwater advises MBO Partenaires on the MBO of Sequoiasoft

Clearwater France advises Cofigeo, backed by MBO Partenaires, on the acquisition of Group William Saurin

Clearwater advises shareholders of Group Location Transport

Clearwater strengthens its foothold in Denmark with the addition of a new Partner

Clearwater advises Meet Recruitment on its MBO supported by NorthEdge

Clearwater France advises Groupe LT’s shareholders on the disposal of the group to MBO Partenaires

Clearwater har rådgivet Dominique Dutscher ved købet af AH Diagnostics

Hemavli Bali

I joined Clearwater in December 2018 to lead M&A advisory within healthcare and life sciences technology and specialist services - including life science commercialisation services, e-clinical solutions, healthcare IT, software and IP driven consultancies. My 21 year career has traversed investment banks, Big Four firms and M&A boutiques and I joined Clearwater for its truly international team, passion for high quality client service, culture and dynamism. I have spent 16 years in M&A advisory, in the UK and the US, and advised on over 40 transactions across the sell- side, buy-side, owner-managed businesses, large corporates, private equity and public to private transactions. I have also provided extensive Board level advice both pre- and post-deal processes. The healthcare and life science industry, and its increasing technology enablement, has been my main focus throughout. Deals I have advised on include the sales of Age UK’s telecare business to Axa PPP Healthcare, Medaxial to Covance, Abacus International to Decision Resources Group and Synergy to DDB, Omnicom. I have previously held roles at Deloitte, Results International, Nomura, Royal Bank of Canada and Ernst & Young. I am a Chartered Accountant and hold a BSc in Economics from the London School of Economics.